Efficacy and Safety of Lixisenatide as Add‐On Therapy to Basal Insulin in Older Adults With Type 2 Diabetes in the GetGoal‐O Study

Background This study compared the efficacy and safety of lixisenatide with placebo as add‐on therapy to basal insulin (BI) in adults aged ≥70 years with type 2 diabetes (T2D), with or without moderate renal insufficiency.